Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04456556
Recruitment Status : Completed
First Posted : July 2, 2020
Last Update Posted : July 2, 2020
Sponsor:
Information provided by (Responsible Party):
Mohamed Farouk Sayed Othman Abelkader, Minia University

Brief Summary:
To report on cases presented with combined endophthalmitis and orbital cellulitis as a first presentation of covid-19 infection.

Condition or disease
Endophthalmitis and Orbital Cellulitis

Detailed Description:
This observation case series study included 5 patients referred to the Ophthalmology Department, Minia University with severe ophthalmic manifestations in the form of combined endophthalmitis and orbital cellulitis. On doing the work-up of covid-19 infection according to the recommendations of Egyptian Ministry of Health, patients proved to be infected by the novel Corona virus. In addition to the Corona work-up, all patients were subjected to full ophthalmological evaluation, ocular ultrasound and orbital CT examination.

Layout table for study information
Study Type : Observational
Actual Enrollment : 5 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19)
Actual Study Start Date : April 27, 2020
Actual Primary Completion Date : June 20, 2020
Actual Study Completion Date : June 30, 2020

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Combined Endophthalmitis and Orbital Cellulitis in patients with Novel Coronavirus Disease (COVID-19) [ Time Frame: baseline ]
    highlight the occurrence of combined endophthalmitis and orbital cellulitis in patients with novel Coronavirus Disease (COVID-19)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
5 patients referred to the Ophthalmology Department, Minia University with severe ophthalmic manifestations in the form of combined endophthalmitis and orbital cellulitis. On doing the work-up of covid-19 infection according to the recommendations of Egyptian Ministry of Health, patients proved to be infected by the novel Corona virus.
Criteria

Inclusion Criteria:

  • Patients with endophthalmitis and orbital cellulitis with covid-19

Exclusion Criteria:

  • Patients without endophthalmitis and orbital cellulitis.
  • Patients with endophthalmitis and orbital cellulitis not having covid-19 infection.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04456556


Locations
Layout table for location information
Egypt
Minia university Hospital
Minya, Minia, Egypt, 61519
Sponsors and Collaborators
Minia University
Publications:
Layout table for additonal information
Responsible Party: Mohamed Farouk Sayed Othman Abelkader, associate professor, Minia University
ClinicalTrials.gov Identifier: NCT04456556    
Other Study ID Numbers: ocular infection in covid19
First Posted: July 2, 2020    Key Record Dates
Last Update Posted: July 2, 2020
Last Verified: June 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Mohamed Farouk Sayed Othman Abelkader, Minia University:
endophthalmitis
orbital cellulitis
covid-19
Additional relevant MeSH terms:
Layout table for MeSH terms
Cellulitis
Endophthalmitis
Orbital Cellulitis
Skin Diseases, Infectious
Infection
Suppuration
Connective Tissue Diseases
Inflammation
Pathologic Processes
Eye Infections
Eye Diseases
Orbital Diseases